adults, and while advances such as GLP-1-based therapies are helping to address this chronic condition, without long-term care and clinical guidance, patients can experience negative impacts to their overall health and sometimes not achieve optimal outcomes," said Hemalee Patel, DO, Senior Medical Director of Cardiometabolic Health, One Medical
What sets it apart is the potential for even greater efficacy, which may outweigh these manageable side effects for many patients
in Nutrients compiled clinical and experimental evidence demonstrating that hydroxytyrosol improves lipid profiles, glycaemia, and insulin sensitivity while counteracting oxidative and inflammatory processes (Peyrol et al., 2017)
Common experiences include no noticeable side effects at standard doses (250-500mcg for injectable, 500mcg for oral)